Gilead Sciences (NQ:GILD)

151.34 -1.16 (-0.76%)

Streaming Delayed Price Updated: 11:14 AM EST, Feb 9, 2026 Add to My Watchlist

Price and Volume

Volume	1,711,886
Open	151.84
Bid (Size)	151.31 (500)
Ask (Size)	151.38 (400)
Prev. Close	152.50
Today's Range	150.39 - 153.00
52wk Range	93.37 - 153.13
Shares Outstanding	1,253,809,440
Dividend Yield	2.09%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Should You Buy Gilead Sciences Before Feb. 10? ↗

Today 10:04 EST

Will the recent momentum be cut short following the biotech's Feb. 10 earnings release, or will it continue?

Via The Motley Fool

Exploring Gilead Sciences's Earnings Expectations ↗

Today 9:01 EST

Via Benzinga

Performance

YTD	+24.5%	+24.5%
1 Month	+25.0%	+25.0%
3 Month	+28.1%	+28.1%
6 Month	+25.6%	+25.6%
1 Year	+58.5%	+58.5%

More News

Gilead Sciences (GILD) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 08, 2026

Via StockStory

FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma

February 06, 2026

From Gilead Sciences, Inc.

Via Business Wire

Gilead Sciences Inc. (NASDAQ:GILD) Passes the Caviar Cruise Quality Investing Screen ↗

January 22, 2026

Via Chartmill

GILEAD SCIENCES INC (NASDAQ:GILD): A High-Yield, Low-Payout Dividend Stock for Disciplined Investors ↗

January 20, 2026

Via Chartmill

Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 5 Years ↗

February 05, 2026

Via Benzinga

This Overlooked Biotech Giant Could Surprise Investors This Quarter

February 05, 2026

Via Barchart.com

1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Challenges

February 02, 2026

Via StockStory

Crossroads4Hope Kicks Off Its 25th Year of Caring with the Launch of Free Breast and Colorectal Cancer Resources for Patients and Families Nationwide

February 02, 2026

Via PRLog

Large Cap Biopharmaceuticals: A Core Position For A Healthcare Portfolio ↗

February 02, 2026

Via Talk Markets

3 Cash-Producing Stocks with Warning Signs

January 29, 2026

Via StockStory

The Commonwealth Club Honors Black History Month With Event Featuring Top Black Leaders in AI & Biopharma Discussing the Future of Healthcare

January 29, 2026

Via Get News

Are Wall Street Analysts Predicting Gilead Sciences Stock Will Climb or Sink?

January 29, 2026

Via Barchart.com

Gilead Sciences to Release Fourth Quarter & Full Year 2025 Financial Results on Tuesday, February 10, 2026

January 27, 2026

From Gilead Sciences, Inc.

Via Business Wire

Demystifying Gilead Sciences: Insights From 17 Analyst Reviews ↗

January 27, 2026

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

January 23, 2026

Via Chartmill

Here's How Much $1000 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today ↗

January 22, 2026

Via Benzinga

New England Journal of Medicine Publishes Phase 3 ASCENT-04/KEYNOTE-D19 Results Supporting Trodelvy® Plus Keytruda® as a Potential New Standard of Care in First-line PD-L1+ Metastatic Triple-negative Breast Cancer

January 21, 2026

From Gilead Sciences, Inc.

Via Business Wire

Gilead Sciences Earnings Preview: What to Expect

January 19, 2026

Via Barchart.com

Looking Into Gilead Sciences Inc's Recent Short Interest ↗

January 16, 2026

Via Benzinga

A New Era in Rare Hepatology: The Deep-Dive Analysis of Mirum Pharmaceuticals (MIRM)

January 13, 2026

Via PredictStreet

J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs ↗

January 08, 2026

Via Stocktwits

The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance

January 07, 2026

Via MarketMinute

Gilead Sciences (GILD): Buy, Sell, or Hold Post Q3 Earnings?

January 05, 2026

Via StockStory

Frequently Asked Questions

Is Gilead Sciences publicly traded?

Yes, Gilead Sciences is publicly traded.

What exchange does Gilead Sciences trade on?

Gilead Sciences trades on the Nasdaq Stock Market

What is the ticker symbol for Gilead Sciences?

The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market

What is the current price of Gilead Sciences?

The current price of Gilead Sciences is 151.34

When was Gilead Sciences last traded?

The last trade of Gilead Sciences was at 02/09/26 11:14 AM ET

What is the market capitalization of Gilead Sciences?

The market capitalization of Gilead Sciences is 189.76B

How many shares of Gilead Sciences are outstanding?

Gilead Sciences has 190B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.